Skip to content

Glaukos GKOS Debt-to-assets

Debt-to-assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.3×0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.3×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
0.2×0.0×
Exelixis logo
ExelixisEXEL
0.1×0.0×

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

Based on the most recent quarter.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's debt-to-assets?
Glaukos (GKOS) reported debt-to-assets of 0.1× in Q1 2026.
How has Glaukos's debt-to-assets changed year-over-year?
Glaukos's debt-to-assets increased by 6.4% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Glaukos's debt-to-assets?
Over 5 years (2020 to 2025), Glaukos's debt-to-assets has grown at a 7.7% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.